Concure Oncology raises $5M from insiders to bring Canadian Breast Microseed therapy to U.S.; available at Swedish Cancer Institute

Concure Oncology raised $5 million from insiders to introduce its Canadian-developed Breast Microseed treatment to the U.S., using implanted radioactive palladium-titanium seeds to deliver targeted post-surgery radiation and reduce breast cancer relapse.

No comments yet.